August 2, 2022
Case experiences with combination therapy with cabozantinib + nivolumab as first-line treatment
August 2, 2022
Long-Term effectiveness results of CheckMate-9ER
August 2, 2022
First-line combination treatments available for renal cell carcinoma
October 12, 2021
Nivolumab + Cabozantinib for the treatment of advanced Renal-Cell Carcinoma in 1L
September 9, 2021